Maurizio D'Incalci

15PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

Kerem Wainer-Katsir, Adi Haber, Hila Fishman

|Mar 31, 2025
Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Joanna Mikulak, Sara Terzoli, Paolo Marzano

|Mar 28, 2025
Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study).

Maria Susanna Grimaudo, Federico D'Orazio, Salvatore Lorenzo Renne

|Oct 17, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study.

Eliana Bignotti, Vittorio Simeon, Laura Ardighieri

|Feb 24, 2024
In-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case.

Laura Mannarino, Nicholas Ravasio, Maurizio D'Incalci

|Dec 06, 2023
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.

Lara Paracchini, Laura Mannarino, Chiara Romualdi

Pageof 3

Frequent Collaborators

4 joint publications

Laura Mannarino

2 joint publications

Monica Lupi

2 joint publications

Lara Paracchini

2 joint publications

Luca Beltrame